Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,799
-7.12%
|
$428,382
$18.73 P/Share
|
|
Feb 26
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-2.99%
|
$78,822
$18.73 P/Share
|
|
Feb 26
2021
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,353
-5.93%
|
$78,354
$18.73 P/Share
|
|
Feb 26
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,060
-4.74%
|
$127,080
$18.73 P/Share
|
|
Feb 26
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.47%
|
$95,000
$19.33 P/Share
|
|
Feb 26
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.45%
|
$30,000
$6.0 P/Share
|
|
Feb 18
2021
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
54,548
-7.32%
|
$1,145,508
$21.01 P/Share
|
|
Feb 18
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
83,332
+9.6%
|
$749,988
$9.42 P/Share
|
|
Feb 11
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,632
-1.08%
|
$37,536
$23.34 P/Share
|
|
Feb 10
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$115,000
$23.88 P/Share
|
|
Feb 10
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Jan 29
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$100,000
$20.34 P/Share
|
|
Jan 29
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Jan 20
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$100,000
$20.41 P/Share
|
|
Jan 20
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Jan 14
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
12,500
-3.86%
|
$237,500
$19.25 P/Share
|
|
Jan 14
2021
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.61%
|
$112,500
$9.42 P/Share
|
|
Jan 04
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
255
+50.0%
|
$4,845
$19.56 P/Share
|
|
Jan 04
2021
|
L Patrick Gage Director |
BUY
Grant, award, or other acquisition
|
Direct |
958
+4.22%
|
$18,202
$19.56 P/Share
|
|
Jan 04
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
511
+26.6%
|
$9,709
$19.56 P/Share
|
|
Jan 04
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
511
+50.0%
|
$9,709
$19.56 P/Share
|
|
Jan 04
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
511
+50.0%
|
$9,709
$19.56 P/Share
|
|
Jan 04
2021
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
511
+50.0%
|
$9,709
$19.56 P/Share
|
|
Jan 04
2021
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
255
+50.0%
|
$4,845
$19.56 P/Share
|
|
Jan 04
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$100,000
$20.23 P/Share
|
|
Jan 04
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Dec 31
2020
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
858
-48.83%
|
$17,160
$20.31 P/Share
|
|
Dec 31
2020
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+32.81%
|
$10,296
$12.96 P/Share
|
|
Dec 16
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$100,000
$20.51 P/Share
|
|
Dec 16
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Dec 15
2020
|
David Cragg Chief HR & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,653
-3.55%
|
$223,713
$21.0 P/Share
|
|
Dec 15
2020
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.26%
|
$149,994
$9.42 P/Share
|
|
Dec 15
2020
|
L Patrick Gage Director |
SELL
Open market or private sale
|
Direct |
7,716
-27.05%
|
$162,036
$21.0 P/Share
|
|
Dec 15
2020
|
L Patrick Gage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,716
+21.29%
|
$92,592
$12.96 P/Share
|
|
Dec 10
2020
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,052
-0.69%
|
$21,040
$20.13 P/Share
|
|
Dec 09
2020
|
Bvf Partners L P |
SELL
Open market or private sale
|
Direct |
430,954
-5.6%
|
$7,757,172
$18.0 P/Share
|
|
Dec 04
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$85,000
$17.36 P/Share
|
|
Dec 04
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.58%
|
$30,000
$6.0 P/Share
|
|
Nov 23
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$75,000
$15.73 P/Share
|
|
Nov 23
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.59%
|
$30,000
$6.0 P/Share
|
|
Nov 12
2020
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,231
-0.81%
|
$20,927
$17.15 P/Share
|
|
Nov 10
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$80,000
$16.5 P/Share
|
|
Nov 10
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.59%
|
$30,000
$6.0 P/Share
|
|
Oct 29
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$75,000
$15.15 P/Share
|
|
Oct 29
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.59%
|
$30,000
$6.0 P/Share
|
|
Oct 13
2020
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.61%
|
$75,000
$15.94 P/Share
|
|
Oct 13
2020
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.59%
|
$30,000
$6.0 P/Share
|
|
Oct 08
2020
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,258
-0.82%
|
$21,386
$17.45 P/Share
|
|
Oct 05
2020
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
50,311
-100.0%
|
$1,509,330
$30.0 P/Share
|
|
Oct 05
2020
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,311
+50.0%
|
$352,177
$7.8 P/Share
|